Our Hot New Alert is….
Blaque Capital Stocks Newsletter
Dear Valued Subscribers, Our hot new pick is :CWNM Please begin your research here:http://crowncddt.com/
CWNM is the home of a revolutionary yet surprisingly simple solution for Controlled Drug Delivery. CWNMs patented and scientifically-proven technology aims not only to improve the safety and pharmacokinetics of controlled-release medication, but also to streamline the manufacturing process for existing facilities without significant upgrade investment.
CWNM`s Controlled Drug Delivery Technology (CDDT) is a novel controlled-release technology, harnessing the principles of diffusion through precise mathematical formulas.
The spectrum and reliability of pharmacokinetic profiles achievable with this technology is superior to currently marketed formulations. Its simple design allows for a high level of flexibility in matching chronotherapeutic requirements. Cost-efficiencies in the commercial manufacturing process, when compared to other drug delivery technologies, may constitute its most important competitive advantage.
The objective of intelligent drug delivery design amounts to maximizing the percent of the time drug plasma levels are within the therapeutic range and avoiding patient exposure to potentially toxic (High) or sub-therapeutic (Low) levels.
CWNM`s cost-effective application of controlled delivery technologies will play a major role in the expansion of the pharmaceutical, OTC and nutraceuticals industry through their ability to improve on the performance of immediate release products in a manner tangible to manufacturers and consumers.
Current CDDT processes, despite continual improvements, still rely on dissolvable coatings or hydrophilic matrix processes to deliver medication over a period of time. Coatings are only effective when they remain intact, causing a potential risk to the patient when cracks or breaks occur in a pill. Hydrophilic matrices, though more effective than traditional coatings, are created from an estimation of stomach acids and other fluids to break down the matrix, and their effectiveness is entirely dependent on each patients body matching these same estimates. Because no two patients are the same, even the most advanced time-release medications can cause potential spikes of toxicity or decreased bioavailability in different patients.
CWNM seeks to change that process entirely, providing for a more sustained and sustainable release of medication in each individual patient through their patented technology. CWNMs process allows for the potential of a true 24-hour sustained-release product without the excessive overhead of chemical remanufacturing for matrix process medications, and without the risks associated with cracked or broken pill coatings.
Recent Corporate Update:
Crown Marketing Reviews Positive In Vivo TestingCWNM is on high alert for tomorrow! Happy Trading! Sincerely, BlaqueCapitalStocks.comThis message was sent to from:
Blaque Capital Stocks | 9613 Wall Street | Manhattan, NY 10016
Related posts:
- ** VIP Early Alert- CWNM is our Extraordinary New Pharmaceutical Epic Pick! **
- CWNM Latest News Could Change The Pharma Industry For Good – Will You Profit From It?
- * CWNM * is our -Red Hot Pharmaceutical Play- for Thursday! Must Read Info Inside…
- * CWNM * This Red Hot Pharmaceutical Alert Could See New Highs Very Shortly
- once again, CWNM, is bringing sexy back